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Clinical features of spinal cord 
hemangioblastoma in a dog
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1 Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN, USA, 
2 Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee,  
Knoxville, TN, USA
A 2-year-old male, intact Yorkshire terrier presented with a 1-month history of progres-
sive paraparesis. Neurological examination revealed paraplegia with absent deep pain 
perception, decreased right pelvic limb withdrawal reflex, and lumbar pain consistent 
with an L4–S2 neurolocalization. Magnetic resonance imaging (MRI) showed a single, 
well-demarcated, intramedullary mass centered over the L3–4 disk space. A hemilami-
nectomy was performed, and the mass was removed en bloc. Histopathological evalu-
ation was consistent with a hemangioblastoma. Follow-up MRI 9 months after surgery 
showed no evidence of tumor recurrence, and the dog was ambulatory paraparetic 
at that time. This case is consistent with a previous histopathological report of spinal 
cord hemangioblastoma in a dog and provides additional clinical information regarding 
diagnosis, treatment, and outcome associated with this tumor type.
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Case presentation
A 2-year-old male, intact Yorkshire terrier [4.77 kg (10.56 lb)] was referred with a 1-month history 
of paraparesis starting in the right pelvic limb. Clinical signs progressed despite treatment with 
prednisone (2 mg/kg/day, PO). On neurological examination, the patient was paraplegic with absent 
deep pain perception in the pelvic limbs. The pelvic limbs had increased extensor tone, normal 
patellar reflexes, normal withdrawal reflex in the left, and decreased withdrawal reflex in the right. 
Pain was elicited on palpation of the lumbar spine. Findings were consistent with a lesion of the 
L4–S2 spinal cord segments.
Complete blood count and serum biochemistry panel and electrolyte analysis were unremarkable. 
Magnetic resonance imaging (MRI; 1.5-T MAGNETOM Espree; Siemens) of the thoracolumbar 
spine revealed a slightly right-sided, discrete, intramedullary mass at the level of the L3–4 interver-
tebral disk space; the mass occupied over 90% of the vertebral canal (Figure 1). The mass was mildly 
hyperintense on T1-weighted (T1W) images, moderately hyperintense on T2-weighted (T2W), 
and short tau inversion recovery images, and showed intense, homogeneous contrast enhancement 
(Magnevist; Bayer). In addition, there was mild T2W and short tau inversion recovery hyperintensity 
within the spinal cord cranial to the mass, most consistent with spinal cord edema. Differential 
diagnoses included primary neoplasia (lymphoma, nephroblastoma, ependymoma, or glioma) and, 
less likely, granuloma. Thoracic radiographs were normal.
A right-sided, L3–4 hemilaminectomy was performed, and a purplish-brown, approximately 1.5-
cm diameter mass was identified beneath the dura. There were prominent meningeal vessels, and 
following a durectomy, the mass was noticed to be highly vascularized around the margins and on 
the surface. Bipolar electrocautery was used to coagulate meningeal and peritumoral vessels. Initially, 
FIGURe 2 | Histological and immunohistochemical sections of spinal 
hemangioblastoma. (a) Predominately spindle cells separated by 
numerous ectatic capillaries (arrow). Hematoxylin and eosin, 10×. (B) Higher 
magnification view of spindle cells (arrow) separated by moderate fibrillary 
stroma. Hematoxylin and eosin, 40×. (C) Spindle cell population and stroma 
within the neoplasm is diffusely positive for neuron-specific enolase. 
Capillaries within the section are negative (arrow; negative internal control), 
20×. (D) Capillaries within the neoplasm are diffusely positive for factor-VIII, 
20×.
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there was no clear plane of dissection between the mass and the 
surrounding spinal cord, so an ultrasonic aspirator (Sonastar 
XS-E, Aesculap, Center Valley, PA, USA) was used to perform the 
initial dissection through the pia as well as the underlying, thin, 
vascular tumor capsule. Once the pia and capsule were removed, 
a plane of dissection was easily distinguished, and the mass was 
removed en bloc. On further gross examination, the mass was 
firm and appeared noticeably more vascular along the surface 
than on the inside.
The dog was hospitalized and received standard post-operative 
care, including intravenous fluids and analgesia. At the time of 
dismissal from the hospital approximately 48 h after surgery, the 
dog was non-ambulatory paraparetic and was voiding voluntarily.
On histopathological evaluation, the spinal mass was com-
posed of mildly pleomorphic spindle cells arranged in loose 
streams and bundles separated by variable amounts of fibrillar 
stroma (Figure  2). The spindle cells had small amounts of 
eosinophilic cytoplasm and irregularly oval nuclei; mitoses were 
rare. Throughout the neoplasm were numerous, often ectatic, 
haphazardly arranged capillaries lined by plump endothelium. 
Frequently surrounding the capillaries were perivascular 
aggregates composed of plasma cells and fewer lymphocytes. 
Immunohistochemically, the spindle cells and stroma were 
strongly and diffusely positive for neuron-specific enolase (NSE) 
and negative for factor-VIII. The capillaries were diffusely factor-
VIII positive and negative for NSE. These findings were consistent 
with a diagnosis of hemangioblastoma.
The dog was re-evaluated at our institution 9 months after sur-
gery. Neurological examination revealed ambulatory paraparesis 
and proprioceptive ataxia in the pelvic limbs with the right limb 
being more severely affected. Postural reactions in the pelvic limbs 
were normal on the left and delayed to absent on the right. Spinal 
pain was not appreciated. Follow-up MRI performed 9 months 
after surgery showed no evidence of tumor recurrence; however, 
FIGURe 1 | pre-operative magnetic resonance images. Sagittal plane 
(a) and transverse plane (B) T2-weighted images showing a hyperintense, 
intramedullary mass at the level of the L3–4 intervertebral disk space 
(asterisk) and associated peritumoral edema cranial to the mass (arrow). 
Sagittal plane (C) and transverse plane (D) post-contrast T1-weighted 
images showing marked, homogenous contrast enhancement of the mass.
spinal cord atrophy was present at the level of the excised heman-
gioblastoma. Hypointense material on pre-contrast T1-weighted 
and post-contrast T1W with Fat Sat images was visible to the right 
of the atrophied spinal cord and corresponded to an area of mixed 
intensity on the T2W images. This material may represent CSF 
and adhesions within the vertebral canal secondary to atrophy 
of the spinal cord and surgery (Figure 3). The application of a 
chemical Fat Sat to the post-contrast T1W image (but not to the 
pre-contrast T1W image) made distinction of this tissue from the 
spinal cord more apparent.
Best veterinary care was practiced in the clinical and diagnos-
tic evaluation as well as treatment of this patient, and the owner 
of the patient provided informed consent for all procedures 
prior to them being performed. As no experimental protocols 
were utilized, an institutional review was neither required nor 
performed.
Background
Hemangioblastomas are rare, benign, highly vascular central 
nervous system tumors. They composed <3% of all central nerv-
ous system tumors in people and occur most commonly in the 
caudal fossa, although 7.5–25% of people develop spinal cord 
lesions (1, 2). Most cases are sporadic, but 23–38% of heman-
gioblastomas occur as a result of Von-Hippel Lindau syndrome 
(VHL), a multi-system cancer disorder caused by a tumor sup-
pressor gene defect (1, 3–5). Patients with VHL are significantly 
more likely to develop lesions within the spinal cord compared to 
those with sporadic hemangioblastomas (2).
FIGURe 3 | post-operative magnetic resonance images acquired 
9 months after surgery. (a) Sagittal plane T2-weighted image showing no 
residual peritumoral edema (asterisks are at the level of the L3–4 
intervertebral disk space). (B) Transverse plane T2-weighted image at the 
level of the L3–4 intervertebral disk space, showing atrophy of the spinal cord 
(arrowhead). Sagittal plane (C) and transverse plane (D) post-contrast 
T1-weighted with Fat Sat images at the level of the L3–4 intervertebral disk 
space. (e) Transverse plane pre-contrast T1-weighted image at the level of 
the L3–4 intervertebral disk space. Atrophied spinal cord is visible in the left 
side of the vertebral canal on all transverse images (arrowhead). The right 
side of the vertebral canal is occupied by material that is hypointense to 
spinal cord on pre-contrast and post-contrast T1-weighted transverse 
images and mixed intensity on T2-weighted transverse image (arrow). This 
material may represent CSF and adhesions at the site of surgery.
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To the best of our knowledge, only two cases of spinal 
hemangioblastoma (SHB) have been reported in dogs (6, 7). 
Furthermore, no prognostic information or long-term follow-up 
information is available because diagnosis was made at necropsy 
in both cases (6, 7). This article describes a case of SHB affecting 
the lumbar spinal cord in a young, adult dog with a focus on clini-
cal features of the disease and long-term follow-up.
Discussion
The clinical, MRI, surgical, and histopathological features of 
this tumor closely resemble descriptions of human hemangio-
blastomas, as well as those of previously reported canine cases. 
Approximately a quarter to a third of central nervous system 
hemangioblastomas in people occur as a result of VHL (4). In 
people with VHL, hemangioblastomas tend to be multiple, 
diagnosed in younger people, and occur more frequently in the 
spinal cord (3). Although there are a few isolated case reports in 
the veterinary literature regarding familial, multi-system cancer 
disorders, to the author’s knowledge, a mutation in the VHL gene 
has not been identified as a cause for these disorders in dogs, nor 
has there been any investigation into the possibility of a familial 
disorder as the cause of hemangioblastomas in dogs (8, 9).
In human patients, SHBs are significantly more likely to 
occur in the cervical or thoracic spinal cord (>90%) (1, 2, 4). The 
location of previously reported cases of SHB in dogs (C7, T1) 
was consistent with the human trend, whereas the SHB in the 
case reported herein had a mid-lumbar location, which is much 
less common in people (6, 7). Up to 75% of human SHBs are 
intramedullary, whereas about 23% are intradural extramedul-
lary (5). The tumor in the current case was intramedullary but 
extended to the pial surface.
Many people with VHL-associated SHB do not have any 
clinical signs referable to the tumor. However, a majority of 
sporadically occurring SHBs are diagnosed after becoming 
symptomatic. In people, clinical signs caused by SHB include 
pain, hypoesthesia, dysesthesia, paresthesia, hyperreflexia, weak-
ness, scoliosis, proprioceptive deficits, spasticity, and bowel and 
bladder abnormalities (4, 5).
Characteristic MRI features of hemangioblastoma in 
people include a well circumscribed, nodular to ovoid-shaped 
mass that is homogenously and intensely contrast enhancing. 
These tumors are T1W isointense or hypointense and T2W 
hyperintense to normal spinal cord parenchyma (10). The 
prevalence of tumor-associated spinal cord edema, peritumoral 
cyst formation, and/or syrinx formation is approximately 75% 
(5). Although these secondary changes can contribute to or be 
primarily responsible for clinical symptoms of the disease, no 
direct treatment is indicated, as these changes almost always 
resolve over time following surgical resection of the tumor (5, 
10). The MRI findings in the case reported here are consistent 
with findings reported in people, except that the SHB reported 
here was hyperintense on T1W sequences. Although no syrinx 
or peritumoral cyst was present, an area of peritumoral edema 
was noted (Figure 1).
Use of radiation therapy, chemotherapy, and stereotactic 
radiosurgery has been reported for the treatment of SHB in 
people, although stereotactic radiosurgery is used primarily for 
treatment of intracranial hemangioblastoma. Despite these alter-
native treatment options, microsurgical resection is considered 
the treatment of choice for SHB in people, and a surgical plane 
of dissection typically facilitates total resection (5). Myelotomy 
might be required for tumors that do not reach the surface of 
the spinal cord (5). A specific method for resection of SHB and 
typical surgical findings has been described in human patients. 
Briefly, following laminectomy, a durectomy is performed on 
midline and the dura is reflected. Supplying and draining vessels 
crossing the margin of the tumor are coagulated, and the pia is 
incised, permitting development of a plane of dissection at the 
interface of the tumor capsule and spinal cord. The tumor is then 
resected circumferentially while applying gentle retraction (11). 
This description closely approximates the intraoperative findings 
and surgical technique used for the en bloc resection of the tumor 
reported here.
Histopathological and immunohistochemical findings in 
this case are consistent with previous veterinary reports of 
hemangioblastoma (6, 7, 12). There is also correlation with 
histopathological descriptions in humans, in which heman-
gioblastomas are described as highly cellular, vascularized, 
and composed of haphazardly oriented, small blood vessels 
lined by a single layer of plump endothelium with pleomorphic 
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stromal cells filling the spaces between the vascular chan-
nels. Immunohistochemistry is critical in the diagnosis of 
hemangioblastoma in people; the stromal component is 
consistently immunoreactive for NSE, S-100 protein, inhibin 
A, and D2-40 while 100% of cases have endothelial cells with 
strong immunoreactivity to factor-VIII (1). This description 
is consistent with the immunoreactivity to NSE and Factor-
VIII in this case.
In a review of all reported cases of sporadic SHB in people 
undergoing surgery, neurological improvement was described 
in 65% of patients whereas 24% remained unchanged (5). 
Recurrence rate for completely resected sporadic SHB is between 
6.25 and 7.7% with partial tumor resection found to be the only 
significant risk factor for recurrence (2, 5).
Concluding Remarks
In conclusion, hemangioblastoma should be considered as a rare 
differential diagnosis for dogs with intramedullary spinal cord 
masses. Evidence from human literature as well as experience 
with this case suggests that en bloc surgical resection is not only 
possible but may be the treatment of choice in dogs. This case 
also demonstrates the possibility of clinical improvement and 
long-term control of the disease with surgical resection alone.
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